Susquehanna International Group, LLP Sorrento Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.74 - $1.83 $926,844 - $2.29 Million	-1,252,492 Reduced 42.57%	1,689,671 $1.5 Million
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $1.23 Million - $2.35 Million	814,923 Added 38.31%	2,942,163 $4.62 Million
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.33 $5,276 - $9,914	-4,255 Reduced 0.2%	2,127,240 $4.28 Million
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $2.75 Million - $6.75 Million	1,376,838 Added 182.45%	2,131,495 $4.97 Million
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $490,891 - $763,256	105,568 Added 16.26%	754,657 $3.51 Million
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $4.17 Million - $6.19 Million	-562,904 Reduced 46.44%	649,089 $4.95 Million
Q2 2021 Aug 11, 2021	BUY	$6.35 - $10.0 $6.73 Million - $10.6 Million	1,060,154 Added 698.21%	1,211,993 $11.7 Million
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $4.42 Million - $10.4 Million	-628,908 Reduced 80.55%	151,839 $1.26 Million
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $757,549 - $1.57 Million	131,519 Added 20.26%	780,747 $5.33 Million
Q3 2020 Nov 16, 2020	SELL	$6.17 - $18.82 $799,724 - $2.44 Million	-129,615 Reduced 16.64%	649,228 $7.24 Million
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $944,202 - $3.69 Million	545,782 Added 234.18%	778,843 $4.89 Million
Q1 2020 May 15, 2020	SELL	$1.57 - $4.76 $52,251 - $158,417	-33,281 Reduced 12.5%	233,061 $429,000
Q4 2019 Feb 14, 2020	BUY	$1.45 - $4.17 $118,931 - $342,031	82,022 Added 44.5%	266,342 $900,000
Q3 2019 Nov 14, 2019	BUY	$2.05 - $2.69 $210,541 - $276,271	102,703 Added 125.84%	184,320 $394,000
Q2 2019 Aug 16, 2019	BUY	$2.67 - $4.38 $18,882 - $30,975	7,072 Added 9.49%	81,617 $218,000
Q2 2019 Aug 14, 2019	SELL	$2.67 - $4.38 $31,412 - $51,530	-11,765 Reduced 13.63%	74,545 $199,000
Q1 2019 May 15, 2019	SELL	$1.86 - $5.94 $35,922 - $114,719	-19,313 Reduced 18.28%	86,310 $410,000
Q1 2018 May 15, 2018	SELL	$4.5 - $9.95 $283,671 - $627,228	-63,038 Reduced 37.38%	105,623 $544,000
Q4 2017 Feb 14, 2018	BUY	$1.75 - $3.8 $196,782 - $427,298	112,447 Added 200.03%	168,661 $641,000
Q3 2017 Nov 14, 2017	BUY	$1.63 - $2.0 $91,628 - $112,428	56,214	56,214 $96,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account